SEC Info - Abvc Biopharma, Inc. - ‘8-K’ for 10/21/22

SEC Info℠

Home

Help

Please Sign In

Abvc Biopharma, Inc. – ‘8-K’ for 10/21/22 – ‘XML’

On: Friday, 10/21/22, at 4:30pm ET · For: 10/21/22 · Accession #: 1213900-22-65540 · File #: 1-40700

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

10/21/22  Abvc Biopharma, Inc.              8-K:4,9    10/21/22   11:318K                                   EdgarAgents LLC/FA

Current Report — Form 8-K

Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: 8-K         Current Report                                      HTML     40K 
 2: EX-16.1     Letter From Kccw Accountancy Corp. to the U.S.      HTML      7K 
                Securities and Exchange Commission                               
 6: R1          Cover                                               HTML     45K 
 9: XML         IDEA XML File -- Filing Summary                      XML     12K 
 7: XML         XBRL Instance -- ea167111-8k_abvcbio_htm             XML     15K 
 8: EXCEL       IDEA Workbook of Financial Reports                  XLSX      8K 
 4: EX-101.LAB  XBRL Labels -- abvc-20221021_lab                     XML     96K 
 5: EX-101.PRE  XBRL Presentations -- abvc-20221021_pre              XML     64K 
 3: EX-101.SCH  XBRL Schema -- abvc-20221021                         XSD     13K 
10: JSON        XBRL Instance as JSON Data -- MetaLinks               25±    33K 
11: ZIP         XBRL Zipped Folder -- 0001213900-22-065540-xbrl      Zip     17K

‘XML’ — XBRL Instance — ea167111-8k_abvcbio_htm

This Document is an XBRL XML File.

<?xml version="1.0" encoding="windows-1252"?>

<link:schemaRef xlink:href="abvc-20221021.xsd" xlink:type="simple"/>

</entity>

</period>

</context>

</unit>

<measure> shares </measure>

</unit>

</unitNumerator>

<measure> shares </measure>

</unitDenominator>

</divide>

</unit>

<dei:EntityCentralIndexKey contextRef="From2022-10-21to2022-10-21"> 0001173313 </dei:EntityCentralIndexKey>

<dei:AmendmentFlag contextRef="From2022-10-21to2022-10-21"> false </dei:AmendmentFlag>

<dei:DocumentType contextRef="From2022-10-21to2022-10-21"> 8-K </dei:DocumentType>

<dei:DocumentPeriodEndDate contextRef="From2022-10-21to2022-10-21"> 2022-10-21 </dei:DocumentPeriodEndDate>

<dei:EntityRegistrantName contextRef="From2022-10-21to2022-10-21"> ABVC BIOPHARMA, INC. </dei:EntityRegistrantName>

<dei:EntityIncorporationStateCountryCode contextRef="From2022-10-21to2022-10-21"> NV </dei:EntityIncorporationStateCountryCode>

<dei:EntityFileNumber contextRef="From2022-10-21to2022-10-21"> 333-91436 </dei:EntityFileNumber>

<dei:EntityTaxIdentificationNumber contextRef="From2022-10-21to2022-10-21"> 26-0014658 </dei:EntityTaxIdentificationNumber>

<dei:EntityAddressAddressLine1 contextRef="From2022-10-21to2022-10-21"> 44370 Old Warm Springs Blvd. </dei:EntityAddressAddressLine1>

<dei:EntityAddressCityOrTown contextRef="From2022-10-21to2022-10-21"> Fremont </dei:EntityAddressCityOrTown>

<dei:EntityAddressStateOrProvince contextRef="From2022-10-21to2022-10-21"> CA </dei:EntityAddressStateOrProvince>

<dei:EntityAddressPostalZipCode contextRef="From2022-10-21to2022-10-21"> 94538 </dei:EntityAddressPostalZipCode>

<dei:CityAreaCode contextRef="From2022-10-21to2022-10-21"> (510) </dei:CityAreaCode>

<dei:LocalPhoneNumber contextRef="From2022-10-21to2022-10-21"> 668-0881 </dei:LocalPhoneNumber>

<dei:WrittenCommunications contextRef="From2022-10-21to2022-10-21"> false </dei:WrittenCommunications>

<dei:SolicitingMaterial contextRef="From2022-10-21to2022-10-21"> false </dei:SolicitingMaterial>

<dei:PreCommencementTenderOffer contextRef="From2022-10-21to2022-10-21"> false </dei:PreCommencementTenderOffer>

<dei:PreCommencementIssuerTenderOffer contextRef="From2022-10-21to2022-10-21"> false </dei:PreCommencementIssuerTenderOffer>

<dei:Security12bTitle contextRef="From2022-10-21to2022-10-21"> Common Stock, par value $0.001 per share </dei:Security12bTitle>

<dei:TradingSymbol contextRef="From2022-10-21to2022-10-21"> ABVC </dei:TradingSymbol>

<dei:SecurityExchangeName contextRef="From2022-10-21to2022-10-21"> NASDAQ </dei:SecurityExchangeName>

<dei:EntityEmergingGrowthCompany contextRef="From2022-10-21to2022-10-21"> false </dei:EntityEmergingGrowthCompany>

</xbrl>

6 Subsequent Filings that Reference this Filing

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 3/25/24  Abvc Biopharma, Inc.              DEFA14A                1:1.6M                                   EdgarAgents LLC/FA
 3/15/24  Abvc Biopharma, Inc.              10-K/A     12/31/23   17:451K                                   EdgarAgents LLC/FA
 3/13/24  Abvc Biopharma, Inc.              10-K       12/31/23   95:8.5M                                   EdgarAgents LLC/FA
12/29/23  Abvc Biopharma, Inc.              DEF 14A     1/16/24    1:10M                                    EdgarAgents LLC/FA
12/15/23  Abvc Biopharma, Inc.              PRE 14A    12/15/23    1:10M                                    EdgarAgents LLC/FA
 3/31/23  Abvc Biopharma, Inc.              10-K       12/31/22   92:8M                                     EdgarAgents LLC/FA

↑Top

Filing Submission 0001213900-22-065540 – Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)

Abvc Biopharma, Inc. – ‘8-K’ for 10/21/22 – ‘XML’

On: Friday, 10/21/22, at 4:30pm ET · For: 10/21/22 · Accession #: 1213900-22-65540 · File #: 1-40700

Current Report — Form 8-KFiling Table of Contents

‘XML’ — XBRL Instance — ea167111-8k_abvcbio_htm

This Document is an XBRL XML File.

6 Subsequent Filings that Reference this Filing

Current Report — Form 8-K

Filing Table of Contents